Milrinone
08-1004
Phase 2 small_molecule completed
Quick answer
Milrinone for Valvular Stenosis is a Phase 2 program (small_molecule) at Stoke Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Stoke Therapeutics
- Indication
- Valvular Stenosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed